Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director comp.
Acq. announced
Appointed director
Notes underwriting agrmnt

MedTech Acquisition Corp Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "STANDBY EQUITY PURCHASE AGREEMENT"
08/23/2023 SC 13G Lombard International Assurance S.A. reports a 5.2% stake in TriSalus Life Sciences Inc.
08/22/2023 SC 13G Stansky Michael P reports a 5.3% stake in TRISALUS LIFE SCIENCES, INC.
08/21/2023 SC 13D MATLIN DAVID J reports a 8.2% stake in TriSalus Life Sciences, Inc.
08/21/2023 SC 13G Dewey Christopher C reports a 5.6% stake in TRISALUS LIFE SCIENCES, INC.
08/21/2023 SC 13D Wahlstrom Mats reports a 10.4% stake in TriSalus Life Sciences, Inc.
08/21/2023 SC 13G MCGREVIN GENE R reports a 5.3% stake in TriSalus Life Sciences, Inc.
08/21/2023 SC 13D Frankenius Equity AB reports a 24.1% stake in TriSalus Life Sciences, Inc.
08/16/2023 8-K Director compensation was amended/approved, Acquisition/merger/asset purchase announced
Docs: "Second Amended and Restated Certificate of Incorporation of TriSalus Life Sciences, Inc",
"Amended and Restated Bylaws of TriSalus Life Sciences, Inc",
"Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of TriSalus Life Sciences, Inc",
"Specimen Common Stock Certificate",
"Specimen Warrant Certificate",
"Description of Common Stock",
"April 5, 2023",
"April 5, 2023",
"April 5, 2023",
"April 5, 2023"
08/14/2023 SC 13D/A Magnetar Financial LLC reports a 4.2% stake in MedTech Acquisition Corp*
08/10/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/09/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/09/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
08/02/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/02/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/02/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders"
08/02/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/02/2023 8-K Quarterly results
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/27/2023 SC 13D/A Magnetar Financial LLC reports a 8% stake in MedTech Acquisition Corp
07/21/2023 8-K Quarterly results
07/19/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/18/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/14/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
07/11/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
07/06/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
07/06/2023 SC 13D MedTech Acquisition Sponsor LLC reports a 84.5% stake in MedTech Acquisition Corporation
07/06/2023 425 Form 425 - Prospectuses and communications, business combinations:
07/06/2023 8-K Entered into an underwriting agreement for the issuance and sale of notes
Docs: "THIRD Amendment To Agreement AND PLAN OF MERGER THIS THIRD AMENDMENT TO AGREEMENT AND PLAN OF MERGER , dated as of July 5, 2023, is made and entered into by and among MedTech Acquisition Corporation, a Delaware corporation , MTAC Merger Sub, Inc., a Delaware corporation and direct, wholly owned subsidiary of Acquiror , and TriSalus Life Sciences, Inc., a Delaware corporation . Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Merger Agreement . RECITALS A. WHEREAS, Acquiror, Merger Sub and the Company are parties to that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended pursuant to that certain First Amendment to Agreement and Plan of Merger, dated as of April 4, 2023 and Second Amendment to Agreement and P...",
"SUBSCRIPTION AGREEMENT",
"Letter re: Termination of Backstop Letter Agreement"
06/30/2023 8-K Unregistered Sales of Equity Securities  Interactive Data
06/15/2023 SC 13D/A Magnetar Financial LLC reports a 61.1% stake in MedTech Acquisition Corp
06/12/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/12/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting",
"TriSalus Corporate Twitter Post We introduced new clinical data at the #ASCO23 Annual Meeting, supporting our hypothesis that SD-101 delivered via TriNav™ using PEDD™ may have favorable immune effects both within the liver and systemically. Learn more: https://trisaluslifesci.com//recent-news/trisalus-life-sciences-presents-additional-data-for-sd-101-delivered-by-the-proprietary-pedd-method-with-the-trinav-device-for-uveal-melanoma-liver-metastases-at-the-asco-2023-annual/ TriSalus Corporate LinkedIn Post"
06/08/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy